Axogen (AXGN) EPS (Weighted Average and Diluted) (2019 - 2026)
Axogen has reported EPS (Weighted Average and Diluted) over the past 10 years, most recently at -$0.38 for Q1 2026.
- For Q1 2026, EPS (Weighted Average and Diluted) fell 375.0% year-over-year to -$0.38; the TTM value through Mar 2026 reached -$0.64, down 326.67%, while the annual FY2025 figure was -$0.34, 47.83% down from the prior year.
- EPS (Weighted Average and Diluted) for Q1 2026 was -$0.38 at Axogen, down from -$0.28 in the prior quarter.
- Over five years, EPS (Weighted Average and Diluted) peaked at $0.01 in Q2 2025 and troughed at -$0.38 in Q1 2026.
- A 5-year average of -$0.13 and a median of -$0.1 in 2022 define the central range for EPS (Weighted Average and Diluted).
- On a YoY basis, EPS (Weighted Average and Diluted) climbed as much as 125.0% in 2025 and fell as far as 2900.0% in 2025.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.13 in 2022, then soared by 30.77% to -$0.09 in 2023, then surged by 111.11% to $0.01 in 2024, then plummeted by 2900.0% to -$0.28 in 2025, then crashed by 35.71% to -$0.38 in 2026.
- Business Quant data shows EPS (Weighted Average and Diluted) for AXGN at -$0.38 in Q1 2026, -$0.28 in Q4 2025, and $0.01 in Q3 2025.